| Literature DB >> 29115927 |
Piotr Andrzej Sass1, Michał Dąbrowski2, Agata Charzyńska2, Paweł Sachadyn3.
Abstract
BACKGROUND: A vast amount of microarray data on transcriptomic response to injury has been collected so far. We designed the analysis in order to identify the genes displaying significant changes in expression after wounding in different organisms and tissues. This meta-analysis is the first study to compare gene expression profiles in response to wounding in as different tissues as heart, liver, skin, bones, and spinal cord, and species, including rat, mouse and human.Entities:
Keywords: Gene expression microarray; Tissue injury; regeneration; Transcriptomics; Wound healing; Wound repair
Mesh:
Year: 2017 PMID: 29115927 PMCID: PMC5678747 DOI: 10.1186/s12864-017-4202-8
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1Data analysis pipeline
Fig. 2Diagrams depicting the procedure of p-value assigning to transcripts differentially regulated in response to wounding. a The histogram of the DBP transcript standardized fold changes in the control samples pooled together for all experiments in the haemostasis phase. Blue bar denotes the number of samples with fold change (FC) less than 0.5. b The histogram of the CEBPB transcript standardized FC in the control samples pooled together for all experiments in the haemostasis phase. Blue bar denotes the number of samples with FC greater than 2.0. c The histogram of the DBP transcript standardized fold changes in the treatment samples pooled together for all experiments in the haemostasis phase. Blue bar denotes the number of samples with FC less than 0.5. d The histogram of the CEBPB transcript standardized fold changes in the treatment samples pooled together for all experiments in the haemostasis phase. Blue bars denote the samples with FC greater than 2. e The theoretical binomial distribution of the DBP transcript standardized FC in the treatment samples under the null hypothesis. The red dots denote the p-value corresponding to the number of treatment sample with FC less than 0.5. f The theoretical binomial distribution of the CEBPB transcript standardized FC in the treatment samples under the null hypothesis. The red dots denote the p-value corresponding to the number of treatment sample with FC greater than 2.0
Fig. 3Step by step procedure of assigning significance (p-value) to a specific transcript differentially regulated in response to wounding
Fig. 4Twenty top-ranked upregulated genes representative of different wound healing phases. Red fields indicate at least a twofold upregulation in the prevailing part of experiments. Green fields indicate at least a twofold downregulation in the prevailing part of experiments. Black fields indicate no substantial changes in gene expression and blank fields indicate no data
Fig. 5Twenty top-ranked downregulated genes representative of different wound healing phases. Red fields indicate at least a twofold upregulation in the prevailing part of experiments. Green fields indicate at least a twofold downregulation in the prevailing part of experiments. Black fields indicate no substantial changes in gene expression and blank fields indicate no data
Fig. 6Ontological categories associated with the genes differentially regulated in different phases of wound response. The gene set enrichment analyses were performed for the top 100 up- and the top 100 downregulated genes for each phase of wound response. The ontological terms were statistically significant as determined by Fisher’s exact test and Benjamini correction for multiple comparisons (p-value adjusted <0.05)
Fig. 7The genes upregulated along different phases of wound response and healing in different tissues. Red fields indicate at least a twofold upregulation in the prevailing part of experiments. Green fields indicate at least a twofold downregulation in the prevailing part of experiments. Black fields indicate no substantial changes in gene expression and blank fields indicate no data
Functions of genes upregulated along different phases of wound response and healing in different tissues
| Gene symbol | Gene name | Function of genes product |
|---|---|---|
|
| Annexin A1 | membrane- phospholipid binding protein which has anti-inflammatory activity |
|
| Annexin A2 | autocrine factor which enhances osteoclast formation and bone resorption |
|
| C-c motif chemokine ligand 2 | factor augmenting anti-tumor activity of monocytes |
|
| CD44 molecule (Indian blood group) | receptor for hyaluronic acid interacting with osteopontin, collagens, and matrix metalloproteinases and involved in lymphocyte activation and homing, haematopoiesis, and metastasis |
|
| Intercellular Adhesion Molecule 1 | cell surface glycoprotein expressed on endothelial and immune system cells |
|
| Galectin 3 | plays a role in numerous cellular functions including apoptosis, innate immunity, cell adhesion and T-cell regulation; exhibits antimicrobial activity |
|
| Matrix metallopeptidase 12 (macrophage elastase) | degrades elastin; involved in extracellular matrix breakdown in development, remodeling but also in aneurysm, metastasis |
|
| Podoplanin | integral membrane glycoprotein proposed as a marker of lung injury |
|
| Protein Tyrosine Phosphatase, Receptor Type C | essential regulator of T- and B-cell antigen receptor signaling; suppresses JAK kinases, thus functioning as a regulator of cytokine receptor signaling |
|
| Secreted Phosphoprotein 1 | involved in the attachment of osteoclasts to the mineralized bone matrix; a cytokine upregulating expression of interferon-gamma and interleukin-12 |
|
| TIMP metallopeptidase inhibitor 1 | inhibits most known matrix metalloproteinases; promotes cell proliferation in a wide range of cell types |
|
| Aquaporin 4 | water-selective channel in the plasma membrane; a predominant aquaporin found in brain |
The information on gene functions was derived from the data collected in the GeneCards database (www.genecards.org), which includes (Entrez Gene summary and UniProtKB/Swiss-Prot:Function)
The downregulated gene is marked with a downwards arrow↓, the upregulated genes are indicated with upwards arrows↑.
The genes which have not been reported so far among the main players in wound response are distinguished with asterisks
Functional annotation for 12 genes differentially regulated throughout all phases of wound response
| Term | Number of genes |
| Genes |
|---|---|---|---|
| GO:0022617~extracellular matrix disassembly | 4 |
|
|
| GO:0005615~extracellular space | 7 |
|
|
| GO:0008360~regulation of cell shape | 4 |
|
|
| GO:0009986~cell surface | 3 |
|
|
| GO:0002548~monocyte chemotaxis | 3 |
|
|
| GO:0070374~positive regulation of ERK1 and ERK2 cascade | 3 | 5.58E-03 |
|
| GO:0030198~extracellular matrix organization | 5 | 6.96E-03 |
|
| GO:0048246~macrophage chemotaxis | 2 | 8.49E-03 |
|
| GO:0006954~inflammatory response | 3 | 2.44E-02 |
|
| GO:0043434~response to peptide hormone | 2 | 2.85E-02 |
|
| GO:0043066~negative regulation of apoptotic process | 3 | 3.43E-02 |
|
| GO:0030593~neutrophil chemotaxis | 2 | 4.24E-02 |
|
The p-values for the terms significant after Benjamini correction (p-value adjusted <0.05) are distinguished with bold font
The 12 genes differentially regulated during all wound healing phases are listed in Fig. 7